CA 15-3
Material: | 1 ml serum (Stability in serum at 4°C – 8°C: 5 days) 1 ml lithium-heparin plasma, EDTA-plasma |
Methods: | Ligandenassays → Chemilumineszenz Mikropartikel Immunoassay (CMIA) | Reference range | < 31 U/ml |
Indication | Therapy- and progress checks in case of mamma carcinoma (together with CEA) |
Comment | Please also refer to: “BRCA1 and BRCA2 mutation analysis” |
Please note | In combination with CEA, CA 15-3 is the most efficient tumor marker for mamma carcinoma. Determination of MCA does not add any further value. Various benign illnesses lead to increased CA 15-3 levels: Myomastopathy, fibro adenoma, liver and pancreas diseases, renal insufficiency, bronchial diseases, also other carcinomas such as ovarial-, bronchial-, pancreas-, liver- and stomach carcinomas. |
Accredited | ja |
Please also refer to: | BRCA1 and BRCA2 mutation analysis |
More Results for the letter C
- Catecholamines in urine (KATU)
- Cationic trypsinogen gene mutation (KATTRY)
- CCP antibodies (CCP)
- Anti-citrulline-antibodies
- CDT (CDT)
- Carbohydrate deficient transferrin, asialotransferrin
- CEA (CEA)
- Carcinoembryonic antigen
- Central European tick-borne encephalitis (CENT01)
- Frühsommer-Meningo-Encephalitis; flavivirus
- Centromere autoantibodies (ZENT)
- Also CENP-A, CENP-B, CENP-C-antibodies
- Cerebrospinal fluid (CEREFL)
- Ceruloplasmin (COERU)
- CFTR gene analysis (CFTR)
- CH50 (CH50)
- Complete hemolytic complement activity
- Chlamydia infections (CHLA)
- Chlamydia trachomatis
- Chlamydia infections (CHLAPN)
- Chlamydophila pneumoniae
- Chlamydia infections (CHLAPS)
- Chlamydophila psittaci
- Chloride in serum (CL)
- Chloride in urine (CLU)
- Chlorprothixene (Chlorp)
- Cholera (KVIBR)
- Vibrio cholerae
- Cholesterol, total (CHOL)
- Cholinesterase (CHE)
- CHE
- Cholinesterase, atypical, molecular genetic evaluation (CHEA)
- Chorea Huntington (CHOREA HUN)
- Huntington’s disease
- Chrome (CHROM)
- chromium
- Chromogranin A (CHROA)
- Chromosome analysis (CHROMO)
- Citalopram (CITA)
- Citrate in the urine (CITU)
- CK (CK)
- Creatine kinase, CK-NAC activated
- CK-isoenzymes (CKISO)
- including macro-CK
- CK-MB mass (CKMB)
- Creatine kinase isoenzyme MB, mass evaluation